Executive functions in premanifest Huntington's disease
- PMID: 24375511
- PMCID: PMC4029327
- DOI: 10.1002/mds.25762
Executive functions in premanifest Huntington's disease
Abstract
Background: We investigated the viability of psychometrically robust executive function measures as markers for premanifest Huntington's disease (HD).
Methods: Fifteen premanifest HD subjects and 42 controls were compared on the NIH EXAMINER executive function battery. This battery yields an overall executive composite score, plus working memory, cognitive control, and fluency scores that are measured on psychometrically matched scales. The scores were correlated with two disease markers, disease burden and striatal volumes, in the premanifest HD subjects.
Results: The premanifest HD subjects scored significantly lower on the working memory score. The executive composite positively correlated with striatal volumes, and the working memory score negatively correlated with disease burden. The cognitive control and fluency scores did not differ between the groups or correlate significantly with the disease markers.
Conclusions: The NIH EXAMINER executive composite and working memory scores are sensitive markers of cognitive dysfunction, striatal volume, and disease burden in premanifest HD.
Keywords: Huntington's disease; disease burden; executive function; striatal volume; working memory.
© 2013 International Parkinson and Movement Disorder Society.
Figures
Similar articles
-
Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.J Huntingtons Dis. 2013;2(2):137-47. doi: 10.3233/JHD-130059. J Huntingtons Dis. 2013. PMID: 25063511
-
The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington's disease individuals.Orphanet J Rare Dis. 2019 Nov 8;14(1):246. doi: 10.1186/s13023-019-1218-y. Orphanet J Rare Dis. 2019. PMID: 31703597 Free PMC article.
-
Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.Mov Disord. 2014 Mar;29(3):320-6. doi: 10.1002/mds.25806. Epub 2014 Feb 5. Mov Disord. 2014. PMID: 24500841
-
Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.J Int Neuropsychol Soc. 2015 Mar;21(3):193-202. doi: 10.1017/S1355617715000090. Epub 2015 Apr 8. J Int Neuropsychol Soc. 2015. PMID: 25850430
-
A review of cognition in Huntington's disease.Front Biosci (Schol Ed). 2013 Jan 1;5(1):1-18. doi: 10.2741/s355. Front Biosci (Schol Ed). 2013. PMID: 23277034 Review.
Cited by
-
Using a Clinical Formulation to Understand Psychological Distress in People Affected by Huntington's Disease: A Descriptive, Evidence-Based Model.J Pers Med. 2022 Jul 27;12(8):1222. doi: 10.3390/jpm12081222. J Pers Med. 2022. PMID: 35893316 Free PMC article.
-
Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's disease.BMJ Open. 2024 Jul 31;14(7):e082161. doi: 10.1136/bmjopen-2023-082161. BMJ Open. 2024. PMID: 39089721 Free PMC article.
-
Digital Cognitive Assessments for Dementia: Digital assessments may enhance the efficiency of evaluations in neurology and other clinics.Pract Neurol (Fort Wash Pa). 2020 Nov-Dec;2020:24-45. Pract Neurol (Fort Wash Pa). 2020. PMID: 33927583 Free PMC article. No abstract available.
-
Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.J Clin Invest. 2014 Oct;124(10):4411-28. doi: 10.1172/JCI74809. Epub 2014 Sep 2. J Clin Invest. 2014. PMID: 25180603 Free PMC article.
-
Non-Verbal and Verbal Fluency in Prodromal Huntington's Disease.Dement Geriatr Cogn Dis Extra. 2015 Dec 18;5(3):517-29. doi: 10.1159/000441942. eCollection 2015 Sep-Dec. Dement Geriatr Cogn Dis Extra. 2015. PMID: 26955384 Free PMC article.
References
-
- Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Psychiatric symptoms in Huntington’s disease before diagnosis: the predict-HD study. Biol Psychiatry. 2007;62:1341–1346. - PubMed
-
- Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study. J Neurol. 2004;251:935–942. - PubMed
Publication types
MeSH terms
Grants and funding
- P50 AG023501/AG/NIA NIH HHS/United States
- R01AG032289/AG/NIA NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 NS053998/NS/NINDS NIH HHS/United States
- HHSN271200623661C/PHS HHS/United States
- R01 AG032289/AG/NIA NIH HHS/United States
- K23AG037566/AG/NIA NIH HHS/United States
- U01 NS058634/NS/NINDS NIH HHS/United States
- R01 HD072074/HD/NICHD NIH HHS/United States
- N01 NS002328/NS/NINDS NIH HHS/United States
- R37 AG031220/AG/NIA NIH HHS/United States
- R01 FD004103/FD/FDA HHS/United States
- R01 NS039074/NS/NINDS NIH HHS/United States
- P50AG023501/AG/NIA NIH HHS/United States
- P01 AG021601/AG/NIA NIH HHS/United States
- T32 AG023481/AG/NIA NIH HHS/United States
- R01 AG031189/AG/NIA NIH HHS/United States
- K23 AG037566/AG/NIA NIH HHS/United States
- K23 AG021989/AG/NIA NIH HHS/United States
- R01 AG022983/AG/NIA NIH HHS/United States
- R01 EB009756/EB/NIBIB NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical